“RevParkinson” App: a digital platform for managing drug treatment and monitoring the evolution of Parkinson’s Disease

Authors

DOI:

https://doi.org/10.9771/cp.v17i1.55417

Keywords:

Adherence, Canvas, Business, Model, Mobile Application.

Abstract

Parkinson's disease is a relatively common condition that requires complex drug treatment to control. This can lead to decreased adherence to treatment due to adverse effects. In view of this, a mobile application "RevParkinson" was devised, which aims to increase adherence to treatment and improve patients' quality of life. This article describes the process of developing the app, using the Canvas Business Model and Value Proposition, in an exploratory and descriptive study. The literature review was discussed by a team and supported the information documented using the Canvas. The application underwent technical testing and validation with users. The validation results demonstrated the app's potential as an instrument capable of increasing adherence to drug therapy in people living with Parkinson's disease, as it meets the proposed requirements and could have a significant impact on disease management and patients' quality of life, providing a new paradigm for digital healthcare.

Downloads

Download data is not yet available.

Author Biographies

Viviane Cristina Cardoso Francisco, Federal University of Amapá, Macapá, AP, Brazil

Master in Health Sciences from the Postgraduate Program in Health Sciences at the Federal University of Amapá in 2014.

Cláudio Márcio Campos de Mendonça, Federal University of Sergipe, São Cristóvão, SE, Brazil

PhD in Administration from the Postgraduate Program in Administration at the Federal University of Rio Grande do Norte in 2015.

Rafael Pontes Lima, Federal University of Amapá, Macapá, AP, Brazil

PhD in Mathematics Education from the Postgraduate Program in Science and Mathematics Education at the Federal University of Mato Grosso in 2015.

Lorane Izabel da Silva Hage-Melim, Federal University of Amapá, Macapá, AP, Brazil

PhD in Sciences from the Faculty of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo in 2009.

References

BALESTRINO, R.; SCHAPIRA, A. H. V. Parkinson disease. European Journal of Neurology: the Official Journal of the European Federation of Neurological Societies, [s.l.], v. 27, n. 1, p. 27-42, 2020.

CARVALHO, A. L. M. et al. Adesão ao tratamento medicamentoso em usuários cadastrados no Programa Hiperdia no município de Teresina (PI). Ciência & Saúde Coletiva, [s.l.], v. 17, n. 7, p. 1.885-1.892, 2012.

CATALAN, V. M. et al. Sistema NAS: Nursing Activities Score em tecnologia móvel. Revista da Escola de Enfermagem da USP, São Paulo, v. 45, n. 6, p. 1.419-1.426, 2011.

CHOU, K. L. Diagnosis and differential diagnosis of Parkinson disease. [S.l.: s.n.], UpToDate, ago. 2020.

FIGUEIREDO, C. M. S.; NAKAMURA, E. Computação móvel: novas oportunidades e novos desafios. T&C Amazônia, [s.l.], v. 1, n. 2, p. 21, 2003.

FREE, C. et al. The effectiveness of M-health technologies for improving health and health services: a systematic review protocol. BMC Research Notes, [s.l.], v. 3, p. 250, 2010.

GADELHA, C. A. G.; COSTA, L. S. Saúde e desenvolvimento no Brasil: avanços e desafios. Revista de Saúde Pública, [s.l.], v. 46, n. suppl 1, p. 13-20, 2012.

GREENHALGH, T.; KOH, G. C. H.; CAR, J. Covid-19: a remote assessment in primary care. BMJ (Clinical research ed.), [s.l.], v. 368, p. m1182, 2020.

GROSSET, D.; EUROPEAN PD THERAPY COMPLIANCE STUDY GROUP. Therapy adherence issues in Parkinson’s disease. Journal of the Neurological Sciences, [s.l.], v. 289, n. 1-2, p. 115-118, 2010.

GROSSET, K. A.; BONE, I.; GROSSET, D. G. Suboptimal medication adherence in Parkinson’s disease. Movement Disorders: Official Journal of the Movement Disorder Society, [s.l.], v. 20, n. 11, p. 1.502-1.507, 2005.

GROZNIK, V. et al. Development, Debugging, and Assessment of Parkinson Check Attributes Through Visualisation. Health Monitoring and Personalized Feedback using Multimedia Data, [s.l.], p. 47-71, 2015.

HAYES, M. T. Parkinson’s disease and parkinsonism. The American Journal of Medicine, [s.l.], v. 132, n. 7, p. 802-807, 2019.

KUBBEN, P. L. et al. TREMOR12: An Open-Source Mobile App for Tremor Quantification. Stereotact Funct Neurosurg, [s.l.], v. 94, n. 3, p. 182-186, 2016.

KUEPPERS, S. et al. From Wellness to Medical Diagnostic Apps: The Parkinson’s Disease Case. In: GIOKAS, K.; BOKOR, L.; HOPFGARTNER, F. (ed.). eHealth 360°. Cham: Springer International Publishing: 2017. p. 384-389.

KUMMER, A. et al. Depression impairs executive functioning in Parkinson disease patients with low educational level. Cognitive and Behavioral Neurology: Official Journal of the Society for Behavioral and Cognitive Neurology, [s.l.], v. 22, n. 3, p. 167-172, 2009.

LAURAITIS, A. et al. A Smartphone Application for Automated Decision Support in Cognitive Task Based Evaluation of Central Nervous System Motor Disorders. IEEE Journal of Biomedical and Health Informatics, [s.l.], v. 23, n. 5, p. 1865-1876, 2019.

OLIVEIRA, A. R.; ALENCAR, M. S. M. O uso de aplicativos de saúde para dispositivos móveis como fontes de informação e educação em saúde. Rev. Digit. Bibliotecon. Cienc. Inf. Campinas, São Paulo, v. 15 n. 1 p. 234-245, 2017.

OROFINO, M. A. R. Técnicas de criação do conhecimento no desenvolvimento de modelos de negócio. Florianópolis: EdUFSC, 2011.

OROZCO-ARROYAVE, J. R. et al. Apkinson: the smartphone application for telemonitoring Parkinson's patients through speech, gait and hands movement. Neurodegener. Dis. Manag., [s.l.], v. 10, n. 3, p. 137-157, 2020.

OSTERWALDER, A. The business model ontology a proposition in a design science approach. 2004. 169f. Tese (Doutorado em Gestão da Informação) – Faculté des Hautes Études Commerciales, Université de Lausanne, Suiça, 2004.

OSTERWALDER, A.; PIGNEUR, Y. Business model generation: A handbook for visionaries, game changers, and challengers. 1. ed. Chichester, England: John Wiley & Sons, 2013.

PRESSMAN, R. S.; BRUCE, R. Engenharia de software-9. Porto Alegre: McGraw Hill Brasil. Ed. 9, 2021.

RIFTIN, Nimrod. eHealth e mHealth: os caminhos da medicina em um país que está envelhecendo. [S.l.: s.n], 2013.

RODRIGUES PEREIRA, N. R. et al. Usability study of a smartphone app entitled: living with Parkinson's disease. Heliyon, [s.l.], v. 9, n. 7, p. e17572, 2023.

ROVINI, E. et al. DAPHNE: a novel e-Health system for the diagnosis and the treatment of Parkinson's Disease. In: CASIDDU, N. et al. (ed.). Ambient Assisted Living: foritaal. Springer: Cham, 2017. Lecture Notes in Electrical Engineering. v. 540. P. 271-288.

SADIKOV, A. Parkinson Check smart phone app. Frontiers in Artificial Intelligence and Applications, [s.l.], v. 263, p. 1.213-1.214, 2014.

SEABURG, L. et al. Shared decision making in atrial fibrillation: where we are and where we should be going: Where we are and where we should be going. Circulation, [s.l.], v. 129, n. 6, p. 704-710, 2014.

STAMATE, C. et al. The cloudUPDRS app: A medical device for the clinical assessment of Parkinson's Disease. Pervasive and Mobile Computing, [s.l.], v. 43, p. 146-166, 2017.

STEPHAN, L. S. et al. Anticoagulação oral na fibrilação atrial: desenvolvimento e avaliação de um aplicativo de saúde móvel para suporte à decisão compartilhada. Arquivos Brasileiros de Cardiologia, [s.l.], v. 110, p. 7-15, 2018.

TARRANTS, M. L. et al. Drug therapies for Parkinson’s disease: A database analysis of patient compliance and persistence. The American journal of geriatric pharmacotherapy, [s.l.], v. 8, n. 4, p. 374-383, 2010.

Published

2024-01-01

How to Cite

Francisco, V. C. C. ., Mendonça, C. M. C. de, Lima, R. P. ., & Hage-Melim, L. I. da S. (2024). “RevParkinson” App: a digital platform for managing drug treatment and monitoring the evolution of Parkinson’s Disease. Cadernos De Prospecção, 17(1), 176–191. https://doi.org/10.9771/cp.v17i1.55417

Issue

Section

Prospecções Tecnológicas de Assuntos Específicos